Melky Cabrera

Cabrera heralded the reemergence of performance enhancing drugs (PEDs) in Major League Baseball when he was busted for testing positive for testosterone during the 2012 season while leading the National League in batting. Just two years earlier, the once promising Yankee outfielder was released by the Atlanta Braves. But then, after a breakout season with the Kansas City Royals, Cabrera was traded to the San Francisco Giants for two players. It was with the Giants that Cabrera bolted out to a great start and his first All-Star Game appearance, but in August, with a NL best .346 average and 159 hits in 113 games, the hammer came down when MLB suspended the outfielder for 50 games, or the rest of the season.

The Yankees inked Cabrera as an unsigned amateur free agent out of the Dominican Republic in 2001, and after a few eye-popping statistical seasons in their minor league system, Melky was tabbed as the Yankee center fielder of the future. But Cabrera never developed into a threat offensively in four full seasons with the Bombers and was dealt after the team won the 2009 World Series. He spent a disappointing season with the Braves before latching on with Kansas City. It seems that it was probably about that time that the outfielder started using PEDs. In 2011 he collected 201 hits, 44 doubles, 18 homers, 87 RBI, and hit .305 – all career bests. He was expected to continue to mature into more of a power threat in San Francisco and was enjoying a fine season when he was suspended. A week later, pitcher Bartolo Colon of the Oakland A’s received a 50-game suspension when it was revealed that he too had tested positive for testosterone.